Jiong Lan

795 total citations
35 papers, 339 citations indexed

About

Jiong Lan is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Jiong Lan has authored 35 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Organic Chemistry and 12 papers in Oncology. Recurrent topics in Jiong Lan's work include Synthetic Organic Chemistry Methods (8 papers), Marine Sponges and Natural Products (8 papers) and Protein Kinase Regulation and GTPase Signaling (6 papers). Jiong Lan is often cited by papers focused on Synthetic Organic Chemistry Methods (8 papers), Marine Sponges and Natural Products (8 papers) and Protein Kinase Regulation and GTPase Signaling (6 papers). Jiong Lan collaborates with scholars based in China, United States and Switzerland. Jiong Lan's co-authors include Zuosheng Liu, Mika Lindvall, Stephen E. Basham, Laura V. Doyle, Anne B. Jefferson, Cynthia M. Shafer, B.A. Appleton, Gordana Atallah, Paul Feucht and Ida Aronchik and has published in prestigious journals such as Blood, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Jiong Lan

31 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiong Lan China 11 202 134 84 44 40 35 339
Naeem Yusuff United States 9 206 1.0× 139 1.0× 107 1.3× 36 0.8× 21 0.5× 11 375
J. Elizabeth Pease United Kingdom 9 211 1.0× 165 1.2× 126 1.5× 75 1.7× 62 1.6× 17 458
Meagan B. Rouse United States 5 179 0.9× 160 1.2× 29 0.3× 31 0.7× 11 0.3× 5 305
E. Hampton Sessions United States 16 295 1.5× 240 1.8× 117 1.4× 13 0.3× 42 1.1× 20 635
Shin Iimura Japan 15 262 1.3× 302 2.3× 95 1.1× 22 0.5× 22 0.6× 26 540
Elena S. Reckzeh Germany 8 275 1.4× 62 0.5× 62 0.7× 12 0.3× 40 1.0× 9 433
Steve Wenglowsky United States 13 188 0.9× 277 2.1× 43 0.5× 48 1.1× 70 1.8× 17 408
Tatiana McHardy United Kingdom 8 281 1.4× 148 1.1× 62 0.7× 34 0.8× 72 1.8× 11 389
Olga E. Andreeva Russia 14 231 1.1× 119 0.9× 66 0.8× 25 0.6× 28 0.7× 40 406
María I. Albarrán Spain 11 199 1.0× 122 0.9× 40 0.5× 61 1.4× 35 0.9× 14 304

Countries citing papers authored by Jiong Lan

Since Specialization
Citations

This map shows the geographic impact of Jiong Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiong Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiong Lan more than expected).

Fields of papers citing papers by Jiong Lan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiong Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiong Lan. The network helps show where Jiong Lan may publish in the future.

Co-authorship network of co-authors of Jiong Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Jiong Lan. A scholar is included among the top collaborators of Jiong Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiong Lan. Jiong Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Tao, Siyuan Le, Leitao Zhang, et al.. (2025). Discovery of Fulzerasib (GFH925) for the Treatment of KRAS G12C-Mutated Solid Tumors. Journal of Medicinal Chemistry. 68(15). 15386–15402.
2.
Wang, Yazhou, Jinxin Liu, Yihong Zhang, et al.. (2025). Rational Design and Identification of ISM7594 as a Tissue-Agnostic FGFR2/3 Inhibitor. Journal of Medicinal Chemistry. 68(13). 13887–13906. 3 indexed citations
3.
Jiang, Tao, Ming Ge, Liang Tao, et al.. (2025). Discovery of a Selective, Novel TGF-βR1 Inhibitor GFH018 for the Treatment of Solid Tumors. Journal of Medicinal Chemistry. 68(12). 12513–12530. 1 indexed citations
5.
Wang, Yini, Bowen Zhong, Caixia Xu, et al.. (2023). Global profiling of AMG510 modified proteins identified tumor suppressor KEAP1 as an off-target. iScience. 26(2). 106080–106080. 10 indexed citations
6.
Zhou, Fusheng, et al.. (2022). In Vitro and In Vivo Studies Support GFH009, a Selective CDK9 Inhibitor, As a Potential Treatment for Hematologic Cancers. Blood. 140(Supplement 1). 7808–7809. 2 indexed citations
7.
Shen, Sida, Zheng Rong Yang, Liang Zhang, et al.. (2018). Discovery of an Orally Bioavailable Dual PI3K/mTOR Inhibitor Based on Sulfonyl-Substituted Morpholinopyrimidines. ACS Medicinal Chemistry Letters. 9(7). 719–724. 10 indexed citations
8.
Lan, Jiong, Abran Costales, Gordana Atallah, et al.. (2018). Design and synthesis of potent RSK inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(19). 3197–3201. 10 indexed citations
9.
Sun, Yu, Yi Hu, Hongmei Zhang, et al.. (2017). Discovery of novel substituted octahydropyrrolo[3,4-c]pyrroles as dual orexin receptor antagonists for insomnia treatment. Bioorganic & Medicinal Chemistry Letters. 27(6). 1458–1462. 10 indexed citations
10.
Zhang, Liang, Wei Liu, Pengfei Cheng, et al.. (2017). Discovery of N-aryl-N′-pyrimidin-4-yl ureas as irreversible L858R/T790M mutant selective epidermal growth factor receptor inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(7). 1257–1261. 6 indexed citations
11.
Han, Wooseok, Daniel L. Menezes, Yongjin Xu, et al.. (2016). Discovery of imidazo[1,2-a]-pyridine inhibitors of pan-PI3 kinases that are efficacious in a mouse xenograft model. Bioorganic & Medicinal Chemistry Letters. 26(3). 742–746. 20 indexed citations
12.
Nishiguchi, Gisele, Matthew T. Burger, Wooseok Han, et al.. (2016). Design, synthesis and structure activity relationship of potent pan-PIM kinase inhibitors derived from the pyridyl carboxamide scaffold. Bioorganic & Medicinal Chemistry Letters. 26(9). 2328–2332. 13 indexed citations
13.
Aronchik, Ida, B.A. Appleton, Stephen E. Basham, et al.. (2014). Novel Potent and Selective Inhibitors of p90 Ribosomal S6 Kinase Reveal the Heterogeneity of RSK Function in MAPK-Driven Cancers. Molecular Cancer Research. 12(5). 803–812. 61 indexed citations
14.
Costales, Abran, Savithri Ramurthy, Jiong Lan, et al.. (2014). 2-Amino-7-substituted benzoxazole analogs as potent RSK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(6). 1592–1596. 24 indexed citations
15.
Pecchi, Sabina, Zhi‐Jie Ni, Wooseok Han, et al.. (2013). Structure guided optimization of a fragment hit to imidazopyridine inhibitors of PI3K. Bioorganic & Medicinal Chemistry Letters. 23(16). 4652–4656. 6 indexed citations
16.
Lan, Jiong, Zuosheng Liu, Lizeng Peng, et al.. (2000). First total synthesis and absolute configuration of marine cembrane diterpenoid (+)-11,12-epoxysarcophytol A. Tetrahedron Letters. 41(13). 2181–2184. 14 indexed citations
17.
Li, Yulin, Zuosheng Liu, Jiong Lan, et al.. (2000). Enantioselective total synthesis of natural 11,12-epoxycembrene-C. Tetrahedron Letters. 41(39). 7465–7469. 4 indexed citations
18.
19.
Lan, Jiong, et al.. (1999). An efficient total synthesis of (±)-sinulariol-B. Tetrahedron. 55(1). 133–140. 8 indexed citations
20.
Liu, Zuosheng, et al.. (1997). First Total Synthesis of (+)-Caparratriene. Chemistry Letters. 26(3). 229–230. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026